Cite

HARVARD Citation

    Huber, S. et al. (n.d.). P411: SF3B1 MUTATIONS IN AML ARE STRONGLY ASSOCIATED WITH MECOM REARRANGEMENTS AND MAY BE INDICATIVE OF AN MDS PRE-PHASE. HemaSphere. pp. 311-312. [Online]. 
  
Back to record